利用疫苗安全数据链监测疫苗安全性:评估整合免疫信息系统中数据的能力
该研究调查了疫苗安全数据链(VSD)的八个数据贡献站点,评估其向免疫信息系统(IIS)发送数据、从IIS接收数据以及将IIS数据整合到站点电子健康记录(EHR)的能力。所有站点均向州IIS发送并接收数据,八个站点(100%)常规将COVID-19疫苗的IIS数据整合到VSD研究中,六个站点(75%)还常规整合所有其他疫苗接种数据;两个站点在核对流程后整合IIS数据,可能导致整合延迟。结论认为所有八个VSD站点接收并整合COVID-19疫苗的IIS数据,使VSD能够开展疫苗安全性的质量评估。
要点
- 所有八个VSD站点均向州IIS发送并接收数据。
- 八个站点(100%)常规将COVID-19疫苗的IIS数据整合到VSD研究中。
- 六个站点(75%)常规整合所有其他疫苗接种数据,两个站点在核对流程后整合,可能导致延迟。
核心结论
- 所有八个VSD站点接收并整合COVID-19疫苗的IIS数据,使VSD能够开展疫苗安全性的质量评估。
- 努力改善所有疫苗接种数据的及时接收将提高VSD内开展疫苗安全性评估的能力。
研究设计与样本
- 研究调查了八个数据贡献VSD站点,评估向IIS发送数据、从IIS接收数据以及将IIS数据整合到站点EHR的状况。
- 站点针对COVID-19疫苗接种单独报告,以捕捉接收和整合COVID-19疫苗与其他疫苗数据能力的差异。
主要发现
- 所有VSD站点均向州IIS发送数据并从州IIS接收数据。
- 所有八个站点(100%)常规将COVID-19疫苗的IIS数据整合到VSD研究中。
- 六个站点(75%)还常规整合所有其他疫苗接种数据;两个站点在核对流程后整合IIS数据,可能导致整合到VSD数据集的延迟。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Vaccine Safety Datalink (VSD) uses vaccination data from electronic health records (EHR) at eight integrated health systems to monitor vaccine safety. Accurate capture of data from vaccines administered outside of the health system is critical for vaccine safety research, especially for COVID-19 vaccines, where many are administered in non-traditional settings. However, timely access and inclusion of data from Immunization Information Systems (IIS) into VSD safety assessments is not well understood. METHODS: We surveyed the eight data-contributing VSD sites to assess: 1) status of sending data to IIS; 2) status of receiving data from IIS; and 3) integration of IIS data into the site EHR. Sites reported separately for COVID-19 vaccination to capture any differences in capacity to receive and integrate data on COVID-19 vaccines versus other vaccines. RESULTS: All VSD sites send data to and receive data from their state IIS. All eight sites (100%) routinely integrate IIS data for COVID-19 vaccines into VSD research studies. Six sites (75%) also routinely integrate all other vaccination data; two sites integrate data from IIS following a reconciliation process, which can result in delays to integration into VSD datasets. CONCLUSIONS: COVID-19 vaccines are being administered in a variety of non-traditional settings, where IIS are commonly used as centralized reporting systems. All eight VSD sites receive and integrate COVID-19 vaccine data from IIS, which positions the VSD well for conducting quality assessments of vaccine safety. Efforts to improve the timely receipt of all vaccination data will improve capacity to conduct vaccine safety assessments within the VSD.
引用
- Groom HC, Crane B, Naleway AL, et al. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems. Vaccine. 2021. PMID: 34980508. doi:10.1016/j.vaccine.2021.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。